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Introduction 
Mutations of several genes encoding the transporters involved in salt reabsorption in the thick 
ascending limb cause different types of Bartter syndrome (BS), with variable phenotypic expression 
and severity. Type I and II are the most severe presenting with polyhydramnios, prematurity and 
characteristically hypokalemia, metabolic alkalosis, polyuria and hypercalciuria. 
Case 
We report the case of a 9 month old girl referred because of fever, vomiting, dehydration and 
electrolyte abnormalities despite fluid administration. 
Medical history revealed unexplained maternal polyhydramnios, prematurity (34weeks) and 
dysmaturity (birth weight 1,75kg). She was admitted in a neonatal unit and after a smooth course, was 
discharged after 36 days (weight 2,2kg). At 4months she presented with feeding difficulties and failure 
to thrive with no biochemical abnormalities or polyuria were . 
At admission, laboratory examination revealed plasma potassium (K) level <3.0 mmol/L, combined 
with inappropriately high excretion (44%), metabolic alkalosis and hypernatremia (154 mmol/l). 
Despite IV fluids the biochemical abnormalities persisted but polyuria became prominent Blood 
pressure (BP) was 115/64mmHg with normal vital parameters. She had pronounced frontal bossing, 
small hands and a wide nose bridge. Neurological examination was normal. 
Additional findings of hyperreninemia hyperaldosteronism, hypercalciuria and nephrocalcinosis were 
suggestive of a tubulopathy, namely BS. However hypernatremia and high BP are no typical features 
of BS. The introduction of indomethacin treatment, in addition to K supplementation, compensation 
of fluid losses and hypercaloric nutrition lead to a stable condition with gradual weight gain. 
Mutational screening revealed a homozygous variant of unknown clinical significance of SLC12A1, a 
gene involved in BS type I. Interestingly there is also a heterozygous gain of function mutation of SCNN1 
gene, usually associated with Liddle syndrome (LS). Further genetic testing, including of the parents, is 
pending. 
Conclusion 
This is the first report of a girl with a phenotypic overlap between BS and LS. Although genetic analysis 
revealed homozygosity for a SLC12A1 variant of unknown significance, clinical picture of BS indicates 
that this is associated with the girl’s disease. The heterozygosity for SCNN1B, with subsequently 
enhanced renal sodium reabsorption, leads us to hypothesize that this variant may balance the renal 
salt wasting caused by BS. 
